Overnight DNA test could speed up cancer care for kids
NCT ID NCT07201038
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a new, ultrafast whole genome sequencing test can give doctors genetic information about a child's cancer within days instead of the usual 1-4 weeks. Researchers at Cambridge University Hospitals will enroll 50 children and young adults under 25 with suspected or confirmed cancer. The goal is to see if faster results can help guide treatment decisions sooner, especially for high-risk cancers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ultrafast whole genome sequencing (WGS)
What this could lead to
If successful, this could replace slower genetic tests, allowing doctors to identify high-risk cancers and start targeted treatments within days instead of weeks.
What could go wrong
This is a small feasibility study with only 50 participants, so results may not apply to all children. The technology may not be fast or reliable enough in routine practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER CHILDHOOD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Addenbrookes Hospital
RECRUITINGCambridge, United Kingdom